drugset / Trial / NCT00587327

Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions

NCT00587327

Phase 2 Completed 125 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this clinical research trial was to evaluate the effects of barusiban and atosiban compared to placebo on luteal phase uterine contractions in oocyte donors supplemented with progesterone.

Timeline

Start
2007-11
Primary completion
2008-05
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atosiban Other / unclassified Intravenous
Subject Barusiban Unknown Intravenous

Indications

No indication recorded.